WORLDWIDE HEALTH SCIENCES PORTFOLIO
NSAR-B, EX-27, 2000-10-30
Previous: WORLDWIDE HEALTH SCIENCES PORTFOLIO, NSAR-B, EX-99, 2000-10-30
Next: ALLIANCE REAL ESTATE INVESTMENT FUND INC /, NSAR-B, 2000-10-30



<TABLE> <S> <C>

<ARTICLE> 6
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-END>                               AUG-31-2000
<INVESTMENTS-AT-COST>                           570535
<INVESTMENTS-AT-VALUE>                          904882
<RECEIVABLES>                                     2448
<ASSETS-OTHER>                                   81022
<OTHER-ITEMS-ASSETS>                                 3
<TOTAL-ASSETS>                                  988356
<PAYABLE-FOR-SECURITIES>                         25614
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                           30
<TOTAL-LIABILITIES>                              25644
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                        628352
<SHARES-COMMON-STOCK>                                0
<SHARES-COMMON-PRIOR>                                0
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                              0
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                        334360
<NET-ASSETS>                                    962712
<DIVIDEND-INCOME>                                 1693
<INTEREST-INCOME>                                   36
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                    4420
<NET-INVESTMENT-INCOME>                         (2690)
<REALIZED-GAINS-CURRENT>                         54650
<APPREC-INCREASE-CURRENT>                       292064
<NET-CHANGE-FROM-OPS>                           344023
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                            0
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                              0
<NUMBER-OF-SHARES-REDEEMED>                          0
<SHARES-REINVESTED>                                  0
<NET-CHANGE-IN-ASSETS>                          757631
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                            0
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                             3291
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                   4573
<AVERAGE-NET-ASSETS>                            421287
<PER-SHARE-NAV-BEGIN>                                0
<PER-SHARE-NII>                                      0
<PER-SHARE-GAIN-APPREC>                              0
<PER-SHARE-DIVIDEND>                                 0
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                                  0
<EXPENSE-RATIO>                                   1.05


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission